Katy Jeannot

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq et al. · The Lancet Infectious Diseases · 2017 · 556 citations · Full text

Prognostic Factors, Foodborne Illness, Clinical Features +6

Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins

Meryem Berrazeg, Katy Jeannot, Véronique Yvette Ntsogo Enguéné et al. · Antimicrobial Agents and Chemotherapy · 2015 · 251 citations · Full text

Microbial Pathogens, Molecular Biology, Antibiotic Resistance +21

A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams in <i>Pseudomonas aeruginosa</i>

Cédric Muller, Patrick Plésiat, Katy Jeannot · Antimicrobial Agents and Chemotherapy · 2010 · 214 citations · Full text

Microbial Pathogens, Bacteriology, Molecular Biology +19

Induction of the MexXY Efflux Pump in <i>Pseudomonas aeruginosa</i> Is Dependent on Drug-Ribosome Interaction

Katy Jeannot, Mara Sobel, Farid El Garch et al. · Journal of Bacteriology · 2005 · 161 citations · Full text

Molecular Biology, Antimicrobial Chemotherapy, Antibiotic Resistance +18

Resistance and Virulence of <i>Pseudomonas aeruginosa</i> Clinical Strains Overproducing the MexCD-OprJ Efflux Pump

Katy Jeannot, Sylvie Elsen, Thilo Köhler et al. · Antimicrobial Agents and Chemotherapy · 2008 · 123 citations · Full text